Competition refresher magazine

Competition refresher magazine

Competition refresher magazine published this article page no 35 while donanemab shows promise it is essential to consider the potential adverse effects associated with drugs that clear out amyloid beta proteins. one notable adverse effect is amyloid-related imaging abnormalities (aria) which may involve brain swelling or bleeding. approximately 24% of participants given donanemab experienced aria-related brain swelling. it is crucial to closely monitor and manage these adverse effects during treatment competition refresher magazine subscription. 

Competition refresher magazine